SUBSCRIBE TO TMCnet
TMCnet - World's Largest Communications and Technology Community

TMCNet:  Research and Markets: Global Hypertension Drugs Market 2014-2018

[June 26, 2014]

Research and Markets: Global Hypertension Drugs Market 2014-2018

DUBLIN --(Business Wire)--

Research and Markets (http://www.researchandmarkets.com/research/8kkxcl/global) has announced the addition of the "Global Hypertension Drugs Market 2014-2018" report to their offering.

The Global Hypertension Drugs market will grow at a CAGR of 1.2% to 2018

Hypertension, also referred as arterial hypertension or high BP, is a chronic medical condition in which the arterial blood pressure is elevated to an undesired level. Lifestyle habits such as diet, exercising, and smoking are the major causes of hypertension.

Hypertension can damage organs and lead to several illnesses such as renal failure, aneurysm, heart failure, stroke, and heart attack. There are two types of hypertension: primary or essential and secondary.

The Global Hypertension Drugs market can be categorized into eight segments:

  • Diuretics
  • ACE Inhibitors
  • ARBs
  • CCB
  • Beta Blockers
  • Alpha Blockers
  • Vasodilators
  • Renin Inhibitors


To calculate the market size, the report considers the revenue generated from the sales of various hypertension drugs used in the treatment of pulmonary arterial hypertension and essential hypertension.

The report, the Global Hypertension Drugs Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global Hypertension Drugs market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Vendors

  • Actelion Ltd.
  • AstraZeneca plc
  • Boehringer Ingelheim GmbH
  • Novartis AG
  • Pfizer Inc.
  • Sanofi SA

Other Prominent Vendors

  • Bayer AG
  • Daiichi Sankyo Co. Ltd.
  • Forest Laboratories Inc.
  • Merck & Co. Inc.
  • Takeda Pharmaceutical Co. Ltd.
  • United Therapeutics Corp.
  • Valeant Pharmaceuticals International Inc.
  • XOMA LLC

Key Market Drivers/Challenges/Trends

  • Increase in Aging Population.
  • Increasing Number of Patent Expirations.
  • Increasing Focus on Combination Therapies.

Key Topics Covered:

  1. Executive Summary
  2. List of Abbreviations
  3. Scope of the Report
  4. Market Research Methodology
  5. Introduction
  6. Market Landscape
  7. Rate of Incidence and Prevalence
  8. Late Stage Pipeline Snapshot
  9. Market Segmentation by Mechanism of Action
  10. Geographical Segmentation
  11. Buying Criteria
  12. Market Growth Drivers
  13. Drivers and their Impact
  14. Market Challenges
  15. Impact of Drivers and Challenges
  16. Market Trends
  17. Trends and their Impact
  18. Vendor Landscape
  19. Key Vendor Analysis

For more information visit http://www.researchandmarkets.com/research/8kkxcl/global


[ Back To Technology News's Homepage ]

OTHER NEWS PROVIDERS







Technology Marketing Corporation

800 Connecticut Ave, 1st Floor East, Norwalk, CT 06854 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments: tmc@tmcnet.com.
Comments about this site: webmaster@tmcnet.com.

STAY CURRENT YOUR WAY

© 2014 Technology Marketing Corporation. All rights reserved.